Trial record 9 of 104 for: "Choreatic Disorders" OR "chorea-acanthocytosis" OR "Chorea, Hereditary" OR "Choreatic Syndrome" OR "Neuroacanthocytosis" OR "Chorea, Chronic Progressive" OR "Chronic Progressive Chorea"
Efficacy and Safety of Tetrabenazine in Chorea
This study has been completed.
Information provided by:
First received: September 14, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
The primary objective of this study was to establish the absolute reduction of chorea in participants with Huntington's disease(HD) treated with tetrabenazine or placebo
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
|Official Title:||A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea|
Resource links provided by NLM:
Genetics Home Reference related topics: chorea-acanthocytosis Huntington disease McLeod neuroacanthocytosis syndromeU.S. FDA Resources
Further study details as provided by Prestwick Pharmaceuticals:
Contacts and Locations